Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril-valsartan in peritoneal dialysis patients with hypertension
jRCT1031250108Recruiting
- Sponsor
- Novartis
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sacubitril + valsartan in hypertension (HTN) and chronic kidney disease (CKD), sponsored by Novartis. Started May 2025; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT1031250108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250108.